SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-054212
Filing Date
2005-03-17
Accepted
2005-03-17 17:32:20
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d20f.htm 20-F 1958293
2 SUBSIDIARIES OF THE REGISTRANT dex8.htm EX-8 19967
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex1001.htm EX-10.01 2689
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex12i.htm EX-12.I 8127
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex12ii.htm EX-12.II 8123
6 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex13.htm EX-13 3914
  Complete submission text file 0001193125-05-054212.txt   2003392
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-16174 | Film No.: 05689874
SIC: 2834 Pharmaceutical Preparations